Skip to main content

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Alphatec Holdings (ATEC) and EyePoint Pharmaceuticals (EYPT)

Tipranks - Tipranks - Thu Jan 8, 9:36AM CST

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Alphatec Holdings (ATEC – Research Report) and EyePoint Pharmaceuticals (EYPT – Research Report).

Claim 70% Off TipRanks Premium

Alphatec Holdings (ATEC)

In a report released today, Thomas Stephan from Stifel Nicolaus maintained a Hold rating on Alphatec Holdings. The company’s shares closed last Wednesday at $21.97.

According to TipRanks.com, Stephan is a 4-star analyst with an average return of 10.5% and a 42.3% success rate. Stephan covers the Healthcare sector, focusing on stocks such as Bausch + Lomb Corporation, TransMedics Group, and Globus Medical. ;'>

Alphatec Holdings has an analyst consensus of Strong Buy, with a price target consensus of $24.55.

See the top stocks recommended by analysts >>

EyePoint Pharmaceuticals (EYPT)

Mizuho Securities analyst Graig Suvannavejh reiterated a Buy rating on EyePoint Pharmaceuticals today and set a price target of $33.00. The company’s shares closed last Wednesday at $17.85.

According to TipRanks.com, Suvannavejh is a 5-star analyst with an average return of 15.8% and a 49.6% success rate. Suvannavejh covers the Healthcare sector, focusing on stocks such as Harmony Biosciences Holdings, Neumora Therapeutics, Inc., and Amylyx Pharmaceuticals Inc. ;'>

The word on The Street in general, suggests a Strong Buy analyst consensus rating for EyePoint Pharmaceuticals with a $31.50 average price target.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).